COVID-19 Cytokine Assay


About this study

The purpose of this research is to evaluate a clinical assay designed to measure biomarkers that will help us understand COVID-19.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Critera:

  • Individuals ≥ 18 and ≤ 60 years of age
  • Has recently been clinically tested for COVID-19 qPCR with either known positive and symptomatic.
  • Patients must be within a radius of Rochester, MN, that allows for reasonable transportation time of the phlebotomist. 

Exclusion Criteria:

  • Patients without prior COVID-19 qPCR results, patients with ambiguous COVID-19 qPCR results.
  • Children under 18 years old or patients over 59 years old.
  • Pregnant women.
  • Patients over 60 years old. 
  • Patients residing beyond a 1 hour drive for the phlebotomist.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Alicia Algeciras-Schimnich, Ph.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Lisa Hines

(507) 293-1638

More information


Publications are currently not available

Mayo Clinic Footer